ASH Abstracts 2019
November 6, 2019
Oncopeptides to highlight data from melflufen clinical program in multiple myeloma and AL Amyloidosis in six presentations at ASH Annual Meeting 2019.
Menu
-
Change Region
-
Global
-
Germany
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our German operations at oncopeptides.de
-
Spain
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our Spanish operations at oncopeptides.es
-
United States
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our US operations at oncopeptides-us.com
Change Language
-
-
ONCO2.13 SEK-3%-0.07 SEK
-
-
Change Region
-
Global
-
Germany
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our German operations at oncopeptides.de
-
Spain
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our Spanish operations at oncopeptides.es
-
United States
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our US operations at oncopeptides-us.com
Change Language
-
-
ONCO2.13 SEK-3%-0.07 SEK
-